Prediabetic neuropathy: Does it exist?

Current Diabetes Reports

Volumn 12, Issue 4, 2012, Pages 376-383

  Papanas, Nikolaos ^a,b   Ziegler, Dan ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Diabetes mellitus; Diabetic neuropathy; Impaired glucose tolerance; Prediabetes

Indexed keywords

GLUCOSE;

ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIABETIC NEUROPATHY; DISEASE SEVERITY; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LONG TERM CARE; METABOLIC SYNDROME X; MICROANGIOPATHY; NERVE CONDUCTION; PATHOGENESIS; PERIPHERAL NEUROPATHY; POPULATION RISK; PREDIABETIC NEUROPATHY; RISK ASSESSMENT; SKIN BIOPSY; TREATMENT PLANNING;

BLOOD GLUCOSE; DIABETIC NEUROPATHIES; FEMALE; GERMANY; GLUCOSE INTOLERANCE; HUMANS; MALE; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDIABETIC STATE; PREVALENCE; RISK FACTORS; TIME FACTORS;

EID: 84865609605     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0278-3     Document Type: Article

References (80)

1. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care. 2005;28:956-62. (Pubitemid 40434506)
2. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-97. (Pubitemid 46148513)
3. Fioretto P, Dodson PM, Ziegler D, Rosenson RS. Residual microvascular risk in diabetes: Unmet needs and future directions. Nat Rev Endocrinol. 2010;6:19-25.
4. Ziegler D. Current concepts in the management of diabetic polyneuropathy. Curr Diabetes Rev. 2011;7:208-20.
5. Ziegler D. Painful diabetic neuropathy: Advantage of novel drugs over old drugs? Diabetes Care. 2009;32 Suppl 2:S414-9.
6. Várkonyi T, Kempler P. Diabetic neuropathy: New strategies for treatment. Diabetes Obes Metab. 2008;10:99-108.
7. Boulton AJ. The diabetic foot: Grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev. 2008;24 Suppl 1:S3-6. (Pubitemid 351802764)
8. Papanas N, Maltezos E. The diabetic foot: Established and emerging treatments. Acta Clin Belg. 2007;62:230-8. (Pubitemid 47234752)
9. Vinik AI, Maser RE, Ziegler D. Neuropathy: The crystal ball for cardiovascular disease? Diabetes Care. 2010;33:1688-90.
10. Hsu WC, Chiu SY, Yen AM, Chen LS, Fann CY, Liao CS, Chen HH. Somatic neuropathy is an independent predictor of all-and diabetes-related mortality in type 2 diabetic patients: A populationbased 5-year follow-up study (KCIS No. 29). Eur J Neurol 2012; Jan 31. [Epub ahead of print].
11. Dyck PJ, Dyck PJ, Klein CJ, Weigand SD. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve. 2007;36:536-41. (Pubitemid 47512081)
12. Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: Does the clock start ticking early? Nat Rev Endocrinol. 2011;7:682-90.
13. Ziegler D, Rathmann W, Dickhaus T, et al. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008;31:464-9. Evidence of peripheral neuropathy in subjects with prediabetes from the general population.
14. Ziegler D, Rathmann W, Dickhaus T, et al. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: The MONICA/ KORA Augsburg Surveys S2 and S3. Pain Med 2009;10:393-400. Evidence that neuropathic pain may be encountered in subjects with prediabetes from the general population.
15. Ziegler D, Rathmann W, Meisinger C, et al. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry. Eur J Pain. 2009;13:582-7.
16. Isak B, Oflazoglu B, Tanridag T, et al. Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev. 2008;24:563-9.
17. Smith AG, Singleton Jr. Impaired glucose tolerance and neuropathy. Neurologist. 2008;14:23-9.
18. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24:1229-31. (Pubitemid 32762153)
19. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve. 2001;24:1225-8. (Pubitemid 32762152)
20. Sumner CJ, Sheth S, Griffin JW, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60:108-11. (Pubitemid 36070653)
21. Smith AG, Singleton Jr. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med. 2004;164:1021-5. (Pubitemid 38581524)
22. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001;24:1448-53. (Pubitemid 33716436)
23. Hoffman-Snyder C, Smith BE, Ross MA, et al. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol. 2006;63:1075-9. (Pubitemid 44232311)
24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29 Suppl 1:S43-8.
25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35 Suppl 1:S64-71.
26. Report of a WHO/IDF Consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. http://whqlibdoc. who.int/publications/ 2006/9241594934-eng.pdf
27. Ziegler D, Papanas N, Heier M, et al. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and prediabetes. The KORA F4 survey. Diabetologia 2011;54:suppl 1:A177.
28. Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29:1294-9. (Pubitemid 44125925)
29. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Invest. 2011;2:18-32.
30. Putz Z, Tabák AG, Tóth N, et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009;32:181-3. Study on the reliable diagnosis of prediabetic neuropathy by clinical examination with emphasis on small fiber function.
31. Smith AG, Ramachandran P, Tripp S, Singleton Jr. Epidermal nerve innervation in impaired glucose tolerance and diabetesassociated neuropathy. Neurology. 2001;57:1701-4. (Pubitemid 33055493)
32. Haanpää ML, Backonja MM, Bennett MI, et al. Assessment of neuropathic pain in primary care. Am J Med. 2009;122(10 suppl): S13-21.
33. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285-93.
34. Hays AP. Utility of skin biopsy to evaluate peripheral neuropathy. Curr Neurol Neurosci Rep. 2010;10:101-7.
35. Lauria G, Bakkers M, Schmitz C, et al. Intraepidermal nerve fiber density at the distal leg: A worldwide normative reference study. J Peripher Nerv Syst 2010;15:202-7. Large series providing reference values of intraepidermal nerve fiber density to diagnose neuropathy.
36. Peltier A, Smith AG, Russell JW, et al. Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve. 2009;39: 529-35.
37. Tavakoli M, Marshall A, Pitceathly R, et al. Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol. 2010;223:245-50.
38. Papanas N, Papatheodorou K, Christakidis D, et al. Evaluation of a new indicator test for sudomotor function (Neuropad®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes. 2005;113:195-8. (Pubitemid 40695323)
39. Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: Clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011 Jun 22; [Epub ahead of print].
40. Kempler P, Amarenco G, Freeman R, et al. Gastrointestinal autonomic neuropathy, erectile-,bladder-and sudomotor dysfunction in patients with diabetes mellitus: Clinical impact, assessment, diagnosis and management. Diabetes Metab Res Rev 2011; Jul 11. [Epub ahead of print].
41. Dobretsov M, Romanovsky D, Stimers Jr. Early diabetic neuropathy: Triggers and mechanisms. World J Gastroenterol. 2007;13:175-91. (Pubitemid 46231321)
42. Russell JW, Sullivan KA, Windebank AJ, et al. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis. 1999;6:347-63. (Pubitemid 29496214)
43. Edwards JL, Quattrini A, Lentz SI, et al. Diabetes regulates mitochondrial biogenesis and fission in mouse neurons. Diabetologia. 2010;53:160-9.
44. Vincent AM, Edwards JL, McLean LL, et al. Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol. 2010;120:477-89.
45. Heine RJ, Balkau B, Ceriello A, et al. What does postprandial hyperglycaemia mean? Diabet Med. 2004;21:208-13. (Pubitemid 38299612)
46. Vincent AM, Hayes JM, McLean LL, et al. Dyslipidemia-induced neuropathy in mice: The role of oxLDL/LOX-1. Diabetes. 2009;58: 2376-85.
47. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48:1856-62. (Pubitemid 29415208)
48. Green AQ, Krishnan S, Finucane FM, Rayman G. Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance. Diabetes Care. 2010;33:174-6.
49. Thrainsdottir S, Malik RA, Dahlin LB, et al. Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes. 2003;52:2615-22. (Pubitemid 37210552)
50. Herman RM, Brower JB, Stoddard DG, et al. Prevalence of somatic small fiber neuropathy in obesity. Int J Obes (Lond). 2007;31:226-35. (Pubitemid 46183127)
51. Smith AG, Rose K, Singleton Jr. Idiopathic neuropathy patients are at high risk for metabolic syndrome. J Neurol Sci. 2008;273:25-8.
52. Pittenger GL, Mehrabyan A, Simmons K, et al. Small fiber neuropathy is associated with the metabolic syndrome. Metab Syndr Relat Disord. 2005;3:113-21. (Pubitemid 41269269)
53. Vincent AM, Hinder LM, Pop-Busui R, Feldman EL. Hyperlipidemia: A new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst. 2009;14:257-67.
54. Rota E, Quadri R, Fanti E, et al. Clinical and electrophysiological correlations in type 2 diabetes mellitus at diagnosis. Diabetes Res Clin Pract. 2007;76:152-4. (Pubitemid 46240360)
55. Smith AG, Bromberg MB. A rational diagnostic approach to peripheral neuropathy. J Clin Neuromuscul Dis. 2003;4:190-8. (Pubitemid 38404429)
56. Hughes RA, Umapathi T, Gray IA, et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain. 2004;127:1723-30. (Pubitemid 39061549)
57. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-24. (Pubitemid 28172927)
58. Kissel JT. Peripheral neuropathy with impaired glucose tolerance: A sweet smell of success? Arch Neurol. 2006;63:1055-6.
59. Franklin GM, Kahn LB, Baxter J, et al. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol. 1990;131:633-43. (Pubitemid 20137231)
60. Feldman EL, Stevens MJ, Thomas PK, et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281-9. (Pubitemid 24324972)
61. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108:477-81. (Pubitemid 43729483)
62. de Neeling JN, Beks PJ, Bertelsmann FW, et al. Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: The Hoorn study. Diabet Med. 1996;13:960-6. (Pubitemid 26384119)
63. Fujimoto WY, Leonetti DL, Kinyoun JL, et al. Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Diabetes. 1987;36:730-9. (Pubitemid 17141112)
64. Shaw JE, Hodge AM, de Courten M, et al. Diabetic neuropathy in Mauritius: Prevalence and risk factors. Diabetes Res Clin Pract. 1998;42:131-9. (Pubitemid 28558952)
65. Eriksson KF, Nilsson H, Lindgärde F, et al. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med. 1994;11:279-85. (Pubitemid 24144144)
66. Dyck PJ, Clark VM, Overland CJ, et al. Impaired glycemia and diabetic polyneuropathy: The OC IG survey. Diabetes Care. 2012;35: 584-91.
67. Barr EL, Wong TY, Tapp RJ, et al. Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab. Diabetes Care. 2006;29:1114-6. (Pubitemid 44115255)
68. Grandinetti A, Chow DC, Sletten DM, et al. Impaired glucose tolerance is associated with postganglionic sudomotor impairment. Clin Auton Res. 2007;17:231-3. (Pubitemid 47358564)
69. Gerritsen J, Dekker JM, TenVoorde BJ, et al. Glucose tolerance and other determinants of cardiovascular autonomic function: The Hoorn Study. Diabetologia. 2000;43:561-70. (Pubitemid 30322073)
70. Singh JP, Larson MG, O'Donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability: The Framingham Heart Study. Am J Cardiol. 2000;86:309-12. (Pubitemid 30462227)
71. Schroeder EB, Chambless LE, Liao D, et al. Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2005;28:668-74. (Pubitemid 40315330)
72. Wu JS, Yang YC, Lin TS, et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab. 2007;92:3885-9.
73. Wu JS, Lu FH, Yang YC, et al. Epidemiological evidence of altered cardiac autonomic function in overweight but not underweight subjects. Int J Obes (Lond). 2008;32:788-94. (Pubitemid 351670616)
74. Stein PK, Barzilay JI, Domitrovich PP, et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study. Diabet Med. 2007;24:855-63. (Pubitemid 47093043)
75. Perciaccante A, Fiorentini A, Paris A, et al. Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord. 2006; 6:19.
76. Singleton JR, Bixby B, Feldman EL, et al. Diet and exercise counseling alone does not prevent long term neuropathy progression in IGTN. [Abstract]. Neurology. 2007;68:A410.
77. Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: The China Da Qing Diabetes Prevention Outcome Study. Diabetologia 2011;54:300-7. Long-term follow-up of subjects with IGT to determine the effect of lifestyle intervention on the development of microvascular complications.
78. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-93. (Pubitemid 36159355)
79. Ziegler D, Zentai CP, Perz S, et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: The MONICA/KORA Augsburg Cohort Study. Diabetes Care. 2008;31:556-61.
80. Beijers HJ, Ferreira I, Bravenboer B, et al. Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality: Evidence for distinct pathways: The Hoorn Study. Diabetes Care. 2009;32:1698-703.